©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 111202
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.111202
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.111202
Table 7 State-of-the-art comparison of very early recurrence studies in pancreatic ductal adenocarcinoma
| Ref. | Sample size | VER definition | Key predictors | Statistical methods | Findings |
| Belfiori et al[6] | 300 | < 12 weeks | Body/tail tumors, G3 tumors | Logistic regression | Higher VER risk in body/tail (HR = 2.34) |
| Strobel et al[14] | 500 | < 6 months | G1 tumors (negative predictor) | Cox regression | G1 predicts long-term survival |
| Current study | 303 | < 12 weeks | G3 tumors, head tumors, RDW | Logistic regression, random forest | G3 strongest predictor (OR = 2.43), AUC 0.75 (random forest) |
- Citation: Martlı HF, İnsan HO, Altaş M, Erişmiş B, Çayhan V, Ersoy O, Keşkek M, Tez M. Clinicopathological features of patients undergoing surgery for pancreatic cancer with very early postoperative recurrence. World J Gastrointest Surg 2025; 17(11): 111202
- URL: https://www.wjgnet.com/1948-9366/full/v17/i11/111202.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.111202